Programmable Infusion Pumps Market by Type and Geography - Forecast and Analysis 2022-2026

The programmable infusion pumps market's growth momentum will accelerate at a CAGR of 7.74% and the market share will increase to USD 598.8 million from 2021 to 2026.

This programmable infusion pumps market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers programmable infusion pumps market segmentation by:

• Type - Large volume infusion pumps and small volume infusion pumps
• Geography - North America, Europe, Asia, and Rest of World (ROW)

The programmable infusion pumps market report also offers information on several market vendors, including Ace Medical Co. Ltd., Arcomed AG, Ascor Med Sp. z o.o., B. Braun SE, Baxter International Inc., Becton Dickinson and Co., Canafusion Technologies Inc., Chemyx Inc., ERENLER MEDIKAL SAN. TIC. Ltd. Sti., Flowonix Medical Inc., Fresenius SE and Co. KGaA, Guangzhou Beaconn Medical Science Technology Co. Ltd., ICU Medical Inc., IRadimed Corp., Johnson and Johnson, Medtronic Plc, Moog Inc., Smiths Group Plc, Terumo Corp., and Ypsomed Holding AG among others.

What will the Programmable Infusion Pumps Market Size be During the Forecast Period?

Download the Free Report Sample to Unlock the Programmable Infusion Pumps Market Size for the Forecast Period and Other Important Statistics

Programmable Infusion Pumps Market: Key Drivers, Trends, and Challenges

Based on our research output, there has been a positive impact on the market growth during and post COVID-19 era. The increasing incidence of chronic diseases is notably driving the programmable infusion pumps market growth, although factors such as the high costs associated with programmable infusion pumps may impede the market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the programmable infusion pumps industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Key Programmable Infusion Pumps Market Driver

• One of the key factors driving growth in the programmable infusion pumps market is the increasing incidence of chronic diseases.
• The incidence and prevalence of chronic diseases, such as diabetes, arthritis, cancer, and obesity, among others, have increased among all age groups of people across the globe. These chronic diseases need long-term treatment with proper therapeutic medications recommended by healthcare professionals.
• Inactive lifestyles, physiological changes, and genetic factors play a major role in the growing burden of chronic diseases among people worldwide. 
• Programmable infusion pumps are majorly used by healthcare professionals to provide proper medication to patients.
• The unique features that are integrated with programmable infusion pumps, such as drug libraries and dose error correction software, aid in providing effective treatment to cancer patients. Therefore, the incidence and prevalence of chronic diseases have increased the demand for programmable infusion pumps and will, therefore, propel the growth of the global programmable infusion pumps market.

Key Programmable Infusion Pumps Market Trend

• Technological advances is a major trend for the programmable infusion pumps market during the forecast period.
• Programmable infusion pumps are primarily used by healthcare professionals for patients suffering from chronic medical conditions or diseases, such as cancer, arthritis, diabetes, and obesity, among others.
• The self-administration capabilities and ease of use of programmable infusion pumps have increased their adoption among the patient population.
• The majority of pharmaceutical and medical device firms are working on adding modern technology to programmable infusion pumps to improve the medication's effectiveness, safety, and efficiency while lowering the risk of adverse responses caused by drug overdose or underdose.
• The advances in programmable infusion pumps are expected to increase the demand for the devices owing to the enhanced self-administration capabilities and the reduced healthcare costs for patients by eliminating the need for frequent hospital visits.

Key Programmable Infusion Pumps Market Challenge

• The high costs associated with programmable infusion pumps will be a major challenge for the programmable infusion pumps market during the forecast period.
• Programmable infusion pumps are more expensive than conventional infusion pumps.
• The average cost of programmable infusion pumps (single channel) ranges between $1,520,000 and $3,500,000. There are two major types of programmable infusion pumps, namely, large-volume pumps and small-volume pumps.
• The maintenance of programmable infusion pumps is crucial to maintain the durability of the devices.
• The software used for programming the infusion pumps is also very expensive. For instance, one-time software licensing fee ranges between $360,000-$400,000.
• The cumulative cost of the infusion pump device, along with the software and drugs or nutrients infused, is expensive. This is expected to hamper the growth of the programmable infusion pumps market across the world.

This programmable infusion pumps market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.

Parent Market Analysis

Technavio categorizes the global programmable infusion pumps market as a part of the global healthcare equipment market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the programmable infusion pumps market during the forecast period.

Who are the Major Programmable Infusion Pumps Market Vendors?

The report analyzes the market's competitive landscape and offers information on several market vendors, including:

• Ace Medical Co. Ltd.
• Arcomed AG
• Ascor Med Sp. z o.o.
• B. Braun SE
• Baxter International Inc.
• Becton Dickinson and Co.
• Canafusion Technologies Inc.
• Chemyx Inc.
• ERENLER MEDIKAL SAN. TIC. Ltd. Sti.
• Flowonix Medical Inc.
• Fresenius SE and Co. KGaA
• Guangzhou Beaconn Medical Science Technology Co. Ltd.
• ICU Medical Inc.
• IRadimed Corp.
• Johnson and Johnson
• Medtronic Plc
• Moog Inc.
• Smiths Group Plc
• Terumo Corp.
• Ypsomed Holding AG

This statistical study of the programmable infusion pumps market encompasses successful business strategies deployed by the key vendors. The programmable infusion pumps market is fragmented and the vendors are deploying growth strategies such as increasing investments, acquisitions, and product launches to compete in the market.

Product Insights and News

• bbraun.com - The company offers programmable infusion pumps such as Infusomat Space which is a volumetric solution to configure customized, tailor-made solutions as individual pumps, small therapy units, or a complex infusion system.
• bbraun.com - Under the B. Braun hospital care segment, the company offers products and services for patients, especially infusion therapy, nutrition therapy, and pain therapy. Its products include infusion and nutrition solutions, as well as specific medications.

To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

The programmable infusion pumps market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.

Programmable Infusion Pumps Market Value Chain Analysis

Our report provides extensive information on the value chain analysis for the programmable infusion pumps market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.

Which are the Key Regions for Programmable Infusion Pumps Market?

For more insights on the market share of various regions Request for a FREE sample now!

33% of the market's growth will originate from North America during the forecast period. US and Canada are the key markets for programmable infusion pumps in North America. However, market growth in this region will be slower than the growth of the market in other regions.

The growing prevalence of chronic diseases, such as diabetes, cancer, and arthritis, among others; the increasing geriatric population; growing technological advances that enable the development of innovative devices; and rising healthcare expenditure will facilitate the programmable infusion pumps market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.

COVID Impact and Recovery Analysis

 In 2020, the demand for programmable infusion pumps in the region increased due to the COVID-19 outbreak. Most hospitalized patients, particularly those in intensive care units, are treated with programmable infusion pumps, which can deliver precise doses at predetermined times. The increase in the demand for programmable infusion pumps in the home care sector, such as enteral feeding pumps and ambulatory infusion pumps, is also driving the growth of the market. 

What are the Revenue-generating Type Segments in the Programmable Infusion Pumps Market?

To gain further insights on the market contribution of various segments Request for a FREE sample

The programmable infusion pumps market share growth by the large volume infusion pumps segment will be significant during the forecast period. Large-volume infusion pumps are majorly used to replace and administer fluids, such as saline solutions, antibiotics, and nutrients to patients. The growing prevalence of various chronic diseases, increasing size and flow rate of large-volume pumps, rising demand from outpatient facilities, and their increasing availability are the major factors contributing to the increasing demand for large-volume infusion pumps.

This report provides an accurate prediction of the contribution of all the segments to the growth of the programmable infusion pumps market size and actionable market insights on post COVID-19 impact on each segment.

Request for a FREE sample

What are the Key Data Covered in this Programmable Infusion Pumps Market Report?

• CAGR of the market during the forecast period 2022-2026
• Detailed information on factors that will drive programmable infusion pumps market growth during the next five years
• Precise estimation of the programmable infusion pumps market size and its contribution to the parent market
• Accurate predictions on upcoming trends and changes in consumer behavior
• The growth of the programmable infusion pumps industry across North America, Europe, Asia, and Rest of World (ROW)
• A thorough analysis of the market's competitive landscape and detailed information on vendors
• Comprehensive details of factors that will challenge the growth of programmable infusion pumps market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch